Wall Street Reacts to Alibaba's Q2 Beat: Three Analysts Adjust Their Price Targets

MarketDash Editorial Team
11 days ago
Alibaba topped earnings expectations with $34.81 billion in revenue and 61 cents per ADS, but heavy investments sent adjusted net income tumbling 72%. Here's how three Wall Street analysts are adjusting their price targets in response.

Alibaba Group Holding (BABA) delivered a solid earnings beat on Tuesday, but the results came with a catch that has analysts recalibrating their expectations.

The Chinese e-commerce giant posted second-quarter revenue of $34.81 billion, climbing 5% year-over-year and sailing past the analyst consensus estimate of $34.43 billion. Adjusted earnings per American Depositary Share came in at 61 cents, significantly topping the 49-cent estimate. On the surface, those are numbers worth celebrating.

But here's where things get interesting. Adjusted net income dropped 72% to $1.45 billion, while adjusted EBITA slipped 78% year-over-year to just $1.27 billion. The culprit? Alibaba is spending aggressively on investments in Taobao Instant Commerce and enhancements to user experiences, plus acquisitions and technology infrastructure. It's the classic growth-versus-profitability trade-off playing out in real time.

Alibaba shares rose 1.3% to trade at $159.02 on Wednesday, suggesting investors are comfortable with the near-term profit sacrifice for long-term positioning.

What the Analysts Are Saying

Three prominent Wall Street analysts updated their views on Alibaba following the earnings release, and while they all maintained bullish ratings, their price target adjustments tell a nuanced story.

Bernstein analyst Robin Zhu kept an Outperform rating but trimmed his price target from $200 to $190. Barclays analyst Jiong Shao maintained an Overweight rating and actually raised his target from $190 to $195. Meanwhile, JP Morgan analyst Alex Yao stuck with an Overweight rating but reduced his price target from $240 to $230.

The mixed price target movements reflect the tension in the story: strong operational performance versus compressed margins from heavy investment spending. All three analysts remain positive on the stock, but they're clearly wrestling with how to value a company that's deliberately prioritizing growth over immediate profitability.

Wall Street Reacts to Alibaba's Q2 Beat: Three Analysts Adjust Their Price Targets

MarketDash Editorial Team
11 days ago
Alibaba topped earnings expectations with $34.81 billion in revenue and 61 cents per ADS, but heavy investments sent adjusted net income tumbling 72%. Here's how three Wall Street analysts are adjusting their price targets in response.

Alibaba Group Holding (BABA) delivered a solid earnings beat on Tuesday, but the results came with a catch that has analysts recalibrating their expectations.

The Chinese e-commerce giant posted second-quarter revenue of $34.81 billion, climbing 5% year-over-year and sailing past the analyst consensus estimate of $34.43 billion. Adjusted earnings per American Depositary Share came in at 61 cents, significantly topping the 49-cent estimate. On the surface, those are numbers worth celebrating.

But here's where things get interesting. Adjusted net income dropped 72% to $1.45 billion, while adjusted EBITA slipped 78% year-over-year to just $1.27 billion. The culprit? Alibaba is spending aggressively on investments in Taobao Instant Commerce and enhancements to user experiences, plus acquisitions and technology infrastructure. It's the classic growth-versus-profitability trade-off playing out in real time.

Alibaba shares rose 1.3% to trade at $159.02 on Wednesday, suggesting investors are comfortable with the near-term profit sacrifice for long-term positioning.

What the Analysts Are Saying

Three prominent Wall Street analysts updated their views on Alibaba following the earnings release, and while they all maintained bullish ratings, their price target adjustments tell a nuanced story.

Bernstein analyst Robin Zhu kept an Outperform rating but trimmed his price target from $200 to $190. Barclays analyst Jiong Shao maintained an Overweight rating and actually raised his target from $190 to $195. Meanwhile, JP Morgan analyst Alex Yao stuck with an Overweight rating but reduced his price target from $240 to $230.

The mixed price target movements reflect the tension in the story: strong operational performance versus compressed margins from heavy investment spending. All three analysts remain positive on the stock, but they're clearly wrestling with how to value a company that's deliberately prioritizing growth over immediate profitability.